EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant TMPRSS6‐Protease Regulation of Disease Mutant HCN4–KCNE1 Channel Complex Depends on the KCNE1‐G38S Polymorphism

David Linhoff, Minay Mertens, Ricarda Zimmermann, Stefan Peischard, Christoph Brenker, Thomas Budde iD, Sven Meuth, Christos Gatsogiannis, Annika Lüttjohann, Liudmila Sosulina, Jürgen Hescheler, Nathalie Strutz-Seebohm und 1 weitere

Archiv der Pharmazie · 2026-06 · 359 (6)

DOI: 10.1002/ardp.70303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 09.07.2026. Verfasst von David Linhoff und 12 weiteren Autor:innen. Beteiligte Einrichtung: GRK 2515, Chemical Biology of Ion Channels (Chembion), Universität Münster, Münster, Germany. Hauptthemen laut MEDLINE: Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Potassium Channels, Voltage-Gated, Serine Endopeptidases, Potassium Channels. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Projektnummer 567500531.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sinoatrial node pacemaker channel HCN4 plays a central role in cardiac automaticity, and disease‐associated variants can predispose to atrial arrhythmias. Here, we investigated the functional interplay between the HCN4 variant P883R and the potassium channel β‐subunit KCNE1, focusing on the common atrial fibrillation–associated KCNE1 variant G38S and its regulation by the iron‐induced serine protease TMPRSS6. Electrophysiological analyses revealed that HCN4‐P883R decreases net HCN4 currents I f , consistent with impaired automaticity. Co‐expression of KCNE1, either wild‐type or polymorphic KCNE1‐G38S, restored functional properties of the mutant channel, indicating that KCNE1 is a key modulator of HCN4 activity. Importantly, TMPRSS6‐mediated proteolytic processing of KCNE1 reduced HCN4 currents, whereas HCN4 expressed alone was insensitive to TMPRSS6, identifying KCNE1 as the direct regulatory target. Notably, KCNE1‐G38S altered the HCN4–KCNE1 complex to TMPRSS6‐dependent downregulation, resulting in a reduced suppression of HCN4‐P883R–mediated currents compared with wild‐type KCNE1. Mechanistically, differential TMPRSS6 cleavage depended on the membrane positioning of the KCNE1‐ 32 RRSPRSS 38 motif. These findings reveal a protease‐dependent buffering mechanism that counteracts HCN4 loss‐of‐function and establish TMPRSS6 as a molecular switch controlling pacemaker activity in a KCNE1 genotype–dependent manner. This dynamic regulatory framework may contribute to the phenotypic variability of sinoatrial node dysfunction and atrial fibrillation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsPotassium Channels, Voltage-GatedSerine EndopeptidasesPotassium ChannelsAtrial FibrillationMembrane ProteinsHumansMutationPolymorphism, GeneticHEK293 CellsAnimalsMuscle Proteins

Stichwörter der Autor:innen

environmentgeneticion channelmodifierproteolysis

Substanzen

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsPotassium Channels, Voltage-GatedKCNE1 protein, humanSerine EndopeptidasesHCN4 protein, humanPotassium ChannelsMembrane ProteinsMuscle Proteins

Autor:innen und Institutionen

  • GRK 2515, Chemical Biology of Ion Channels (Chembion), Universität Münster, Münster, Germany.
  • Department of Cardiovascular Medicine, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.
  • Centre of Reproductive Medicine and Andrology, University Hospital Münster, University of Münster, Münster, Germany.
  • Institut für Physiologie I, Münster, Germany.
  • Klinik für Neurologie mit Institut für Translationale Neurologie, ICB, Münster, Germany.
  • Institute for Medical Physics and Biophysics and Center for Soft Nanoscience, Universität Münster, Münster, Germany.

ORCID-Profile: Thomas Budde, Guiscard Seebohm

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Projektnummer 567500531

Zitieren

APA

Linhoff, D., Mertens, M., Zimmermann, R., Peischard, S., Brenker, C., Budde, T., Meuth, S., Gatsogiannis, C., Lüttjohann, A., Sosulina, L., Hescheler, J., Strutz-Seebohm, N., & Seebohm, G. (2026). Aberrant TMPRSS6‐Protease Regulation of Disease Mutant HCN4–KCNE1 Channel Complex Depends on the KCNE1‐G38S Polymorphism. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70303

Vancouver

Linhoff D, Mertens M, Zimmermann R, Peischard S, Brenker C, Budde T, et al. Aberrant TMPRSS6‐Protease Regulation of Disease Mutant HCN4–KCNE1 Channel Complex Depends on the KCNE1‐G38S Polymorphism. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70303

BibTeX
@article{Linhoff2026,
  author = {Linhoff, David and Mertens, Minay and Zimmermann, Ricarda and Peischard, Stefan and Brenker, Christoph and Budde, Thomas and Meuth, Sven and Gatsogiannis, Christos and Lüttjohann, Annika and Sosulina, Liudmila and Hescheler, Jürgen and Strutz-Seebohm, Nathalie and Seebohm, Guiscard},
  title = {Aberrant TMPRSS6‐Protease Regulation of Disease Mutant HCN4–KCNE1 Channel Complex Depends on the KCNE1‐G38S Polymorphism},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {6},
  doi = {10.1002/ardp.70303}
}
Kostenlos starten →